| 查看: 1483 | 回复: 4 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
[交流]
急。求助翻译。质量一般就行，不要机译。谢谢
|
|||
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. Nanoparticles were then adsorbed by passing the nanodispersion through a Neusilin US2 (adsorbent) column. Interestingly, scanning electron microscopy revealed round deformed and even collapsed nanoparticles in Buffer-I and discrete spherical to ellipsoidal nanoparticles in Buffer-II which indicates the inability of nanoemulsion to crystallize and form SLN in Buffer-I. The successful formation of SLN in Buffer-II was confirmed by differential scanning calorime try and X-ray diffraction. The retention of SLN from the nanodispersion by adsorption on the adsorbent imparted good flow property and resulted in a marked stability improvement of the formulation in terms of drug retention efficiency and release profile as compared to the simple nanosuspension. In conclusion, the adsorbent technology would be instrumental in imparting additional features to the existing conventional colloidal system for pharmaceutical application which would ease the process of capsule filling at industrial scale, simplify the handling of formulations by patients and can significantly improve the shelf life of the product for a longer period of time as compared to liquid formulations. improve stability. However, the coexistence of high concentration of stabilizing agents (surfactants) along with the lipid nanopartiSolid lipid based colloidal carriers of drugs have attracted considerable attention in the last two decades [1–4]. As they are derived from physiologically compatible lipids, solid lipid nanoparticles (SLN) represent a safe and effective alternative which include additional advantages and are devoid of the potential toxicities of conventional polymeric nanoparticles [5–7]. SLN for oral drug administration have specifically been employed for improving bioavailability by targeting the uptake of the drug by lymphatic system which prevents its hepatic first pass metabolism [8–11]. Despite the perceived therapeutic advantages of SLN, the technology available so far for the fabrication of SLN is restricted to the development of nanodispersion which has not had been so encouraging. In an aqueous nanodispersion, the SLN have a tendency to undergo particle aggregation under accelerated storage conditions due to the gelation phenomenon (an irreversible conversion of low viscosity lipid based nanoparticles dispersion into a viscous gel) due to which the dispersion is usually lyophilized into a dry powder to cles (LNs) in the final product is not desirable because of their toxic effects on the mucosal lining of the GIT. Moreover, the process of lyophilization is critical as rate of freezing governs the structure and properties of the lipid crystals which finally determines its drug retention capacity during storage. Alternatively, filtration of the nanoparticles as a whole is a costly and exhaustive process due to the requirement of sophisticated equipments for retaining particles in nanosize range. Apart from the above, surfactants essentially employed in the production of SLN increase solubility of the poorly soluble/insoluble drug in the external phase. This matter is of serious concern during production and upon long term storage as it results in progressive leaching of drug from the particles to external phase which results in reduced drug loading efficiency. The above issues have been discussed in detail in literature [12].The above discussion indicates that there is a necessity to develop a method which can separate the nanoparticles from the dispersion and immobilize them in order to retain their individual morphological identity upon storage. Harvesting the SLN from the nanodispersion by surface adsorption or retention on a submicron size inert pharmaceutical excipient with good flowability, compressibility and adsorption capacity may be an excellent approach to overcome the above mentioned issues. The prepared “Adsorbed Lipid Nanoparticles” (ALN) would not only maintain the integrity of each adsorbed nanoparticle but also ease its filling into capsules or compression into tablet. To our knowledge, such a unique approach in the development of SLN delivery system has not been reported so far. However, limited studies involving the use of adsorbents to obtain lipid based granules for oral drug delivery have been reported wherein adsorbents were found to enhance the bioavailability of the drug and impart significant flow and compressibility to the final blend [13–15].The drug employed here is carvedilol phosphate, a non-selective-blocker. The drug exhibits poor aqueous solubility and highlipophilicity (log P) which makes it an excellent candidate for SLN encapsulation[16,17]. A study conducted previously in our laboratory using different types and concentration of surfactants at different pH has shown that sodium taurocholate (STC) has both minimum molar solubilization capacity and binding constant for carvedilol phosphate at pH 7.2 [18]. Therefore, the objective of the present work was to develop SLN of carvedilol phosphate using STC as a stabilizing agent and pH 7.2 phosphate buffer as dispersion medium, and improve the physicochemical properties of the nanoparticles by adsorbing them onto Neusilin (magnesium aluminometasilicate), an inert pharmaceutical excipient used as adsorbent. 2. Materials and methods [ Last edited by kaichang on 2011-1-9 at 13:15 ] |
回复此楼» 猜你喜欢
29号明天会评吗
已经有4人回复
-
国社科又开始会评了，不知道这次命运如何
已经有10人回复
-
梦想
已经有4人回复
-
中青基了要发朋友圈吗？
已经有6人回复
-
基金不中，共勉
已经有12人回复
-
能否申诉？
已经有7人回复
-
有多少人是今天查系统知道结果的？
已经有19人回复
-
面上意见出来了
已经有19人回复
-
为什么到现在没收到通知？
已经有5人回复
-
有没有仍没收到信息的
已经有8人回复
» 抢金币啦！回帖就可以得到:
-
面上中了，散金币。
+5/1520
-
云南大学丁军桥团队2027年博士招生
+1/945
-
八年奋战，面上中了，同时一个读了8年的博士（中途接手）答辩通过了，都是涉险过关
+2/368
-
征友避雷上海【荀玄武】
+1/95
-
原子层沉积（ALD）磁控溅射PECVD等微纳代工服务：18817872921
+1/91
-
东南大学能源与环境学院-林日琛教授课题组-27级博士招生
+1/91
-
东南大学能源与环境学院-林日琛教授课题组-27级博士招生
+1/90
-
东南大学能源与环境学院-林日琛教授课题组-27级博士招生
+1/90
-
东南大学能源与环境学院-林日琛教授课题组-27级博士招生
+1/87
-
今日少年明日老。
+1/77
-
深圳大学刘翼振课题组诚聘博士后（CRISPR分子诊断）
+1/39
-
四川大学高分子学院、空天学院招收研究助理
+1/28
-
2024级硕士求推荐博导-计算模拟背景
+3/14
-
北京师范大学（珠海）化学传感与成像课题组2026年研究生（统招/推免）招生
+1/8
-
中国科学院广州生物医药与健康研究院课题组招收博士研究生1名（2027年9月入学）
+1/6
-
AFM｜天津科技大学&华东师范大学设计四氮基COF，开辟太阳光制备H2O2高效新路径
+1/5
-
2026年工程管理与智慧城市国际会议 (EMSC 2026)
+1/4
-
香港大学智能制造实验室招收27年春秋季入学全奖博士和硕士研究生
+1/3
-
项目助理招聘启事
+1/2
-
香港大学先进制造实验室招收全奖博士和硕士研究生
+1/1
kaichang(金币+2, 翻译EPI+1):尽管只有一句，不过还是谢谢。有空就全部帮我翻译了吧。 2011-01-09 18:51:36
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristics for improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。 |
2楼2011-01-09 17:21:15
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。基于卡维地洛磷酸盐的硬脂酸是由溶剂乳化蒸发技术制得，该过程是在1%的聚乙烯醇产生的ph值为7.2的缓冲池中制备的牛黄胆酸钠中完成的。 |
3楼2011-01-09 18:51:08
4楼2011-01-10 00:05:25
5楼2011-01-10 01:12:07
投票:
